Comments
Loading...
Veracyte (NASDAQ:VCYT) Stock Quotes, Forecast and News Summary
Veracyte Stock (NASDAQ: VCYT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Veracyte (VCYT) stock?
You can purchase shares of Veracyte (NASDAQ:VCYT) through any online brokerage.
Who are Veracyte (VCYT) competitors?
Other companies in Veracyte’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX) and PTC Therapeutics (NASDAQ:PTCT).
What is the forecast, or price target, for Veracyte (VCYT) stock?
Veracyte has a consensus price target of $38.78.
What is the current price for Veracyte (VCYT)?
The stock price for Veracyte (NASDAQ: VCYT) is $40.145 last updated November 25, 2024 at 12:50 PM EST.
Does Veracyte (VCYT) pay a dividend?
There are no upcoming dividends for Veracyte.
When is Veracyte (NASDAQ:VCYT) reporting earnings?
Veracyte’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is Veracyte (VCYT) going to split?
There is no upcoming split for Veracyte.
What sector and industry does Veracyte (VCYT) operate in?
Veracyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.